Synergy Of Tlr4 Agonist Gsk1795091, An Innate Immune Activator, With Agonistic Antibody Against Co-Stimulatory Immune Checkpoint Molecule Ox40 In Cancer Immunotherapy.

JOURNAL OF CLINICAL ONCOLOGY(2018)

引用 8|浏览30
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要